エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/02 | 4,101 | 4,121 | 3,925 | 3,925 | -180 | -4.4% | 2,969,900 |
| 2025/04/01 | 4,145 | 4,185 | 4,102 | 4,105 | -40 | -1% | 1,454,500 |
| 2025/03/31 | 4,247 | 4,249 | 4,142 | 4,145 | -162 | -3.8% | 2,022,500 |
| 2025/03/28 | 4,300 | 4,316 | 4,260 | 4,307 | -63 | -1.4% | 1,206,900 |
| 2025/03/27 | 4,329 | 4,370 | 4,317 | 4,370 | +49 | +1.1% | 1,396,700 |
| 2025/03/26 | 4,300 | 4,348 | 4,298 | 4,321 | ±0 | ±0% | 1,438,500 |
| 2025/03/25 | 4,311 | 4,335 | 4,293 | 4,321 | +11 | +0.3% | 1,080,100 |
| 2025/03/24 | 4,356 | 4,365 | 4,310 | 4,310 | -22 | -0.5% | 840,700 |
| 2025/03/21 | 4,322 | 4,350 | 4,290 | 4,332 | -15 | -0.3% | 1,697,500 |
| 2025/03/19 | 4,341 | 4,377 | 4,327 | 4,347 | +47 | +1.1% | 788,400 |
| 2025/03/18 | 4,344 | 4,344 | 4,290 | 4,300 | -7 | -0.2% | 1,059,900 |
| 2025/03/17 | 4,274 | 4,320 | 4,268 | 4,307 | +34 | +0.8% | 819,100 |
| 2025/03/14 | 4,226 | 4,279 | 4,220 | 4,273 | +16 | +0.4% | 1,120,400 |
| 2025/03/13 | 4,257 | 4,268 | 4,229 | 4,257 | -11 | -0.3% | 796,800 |
| 2025/03/12 | 4,235 | 4,273 | 4,207 | 4,268 | -2 | ±0% | 1,105,300 |
| 2025/03/11 | 4,259 | 4,299 | 4,245 | 4,270 | -16 | -0.4% | 1,162,900 |
| 2025/03/10 | 4,250 | 4,287 | 4,233 | 4,286 | +55 | +1.3% | 1,118,600 |
| 2025/03/07 | 4,260 | 4,282 | 4,215 | 4,231 | -77 | -1.8% | 1,616,100 |
| 2025/03/06 | 4,268 | 4,308 | 4,245 | 4,308 | +47 | +1.1% | 833,800 |
| 2025/03/05 | 4,270 | 4,287 | 4,224 | 4,261 | +20 | +0.5% | 920,600 |
| 2025/03/04 | 4,245 | 4,303 | 4,225 | 4,241 | -49 | -1.1% | 1,150,100 |
| 2025/03/03 | 4,379 | 4,381 | 4,257 | 4,290 | -19 | -0.4% | 1,274,800 |
| 2025/02/28 | 4,400 | 4,417 | 4,280 | 4,309 | -118 | -2.7% | 2,403,300 |
| 2025/02/27 | 4,432 | 4,450 | 4,398 | 4,427 | -13 | -0.3% | 811,500 |
| 2025/02/26 | 4,400 | 4,440 | 4,370 | 4,440 | +68 | +1.6% | 1,080,200 |
| 2025/02/25 | 4,279 | 4,377 | 4,277 | 4,372 | +93 | +2.2% | 1,217,700 |
| 2025/02/21 | 4,260 | 4,305 | 4,250 | 4,279 | +37 | +0.9% | 831,200 |
| 2025/02/20 | 4,315 | 4,328 | 4,227 | 4,242 | -79 | -1.8% | 1,210,200 |
| 2025/02/19 | 4,364 | 4,380 | 4,315 | 4,321 | -51 | -1.2% | 728,400 |
| 2025/02/18 | 4,335 | 4,384 | 4,293 | 4,372 | +12 | +0.3% | 760,400 |
| 2025/02/17 | 4,373 | 4,389 | 4,347 | 4,360 | -5 | -0.1% | 656,300 |
| 2025/02/14 | 4,413 | 4,428 | 4,330 | 4,365 | -54 | -1.2% | 1,044,400 |
| 2025/02/13 | 4,402 | 4,485 | 4,402 | 4,419 | +110 | +2.6% | 1,315,300 |
| 2025/02/12 | 4,445 | 4,449 | 4,305 | 4,309 | -143 | -3.2% | 1,878,300 |
| 2025/02/10 | 4,502 | 4,542 | 4,370 | 4,452 | -54 | -1.2% | 1,519,500 |
| 2025/02/07 | 4,467 | 4,674 | 4,448 | 4,506 | +5 | +0.1% | 2,537,600 |
| 2025/02/06 | 4,391 | 4,512 | 4,391 | 4,501 | +124 | +2.8% | 1,124,200 |
| 2025/02/05 | 4,419 | 4,430 | 4,352 | 4,377 | -79 | -1.8% | 1,193,000 |
| 2025/02/04 | 4,492 | 4,516 | 4,448 | 4,456 | +32 | +0.7% | 984,400 |
| 2025/02/03 | 4,455 | 4,463 | 4,392 | 4,424 | -197 | -4.3% | 2,048,300 |
| 2025/01/31 | 4,646 | 4,652 | 4,609 | 4,621 | -14 | -0.3% | 1,275,000 |
| 2025/01/30 | 4,601 | 4,645 | 4,594 | 4,635 | +4 | +0.1% | 1,134,000 |
| 2025/01/29 | 4,710 | 4,715 | 4,601 | 4,631 | -78 | -1.7% | 1,629,500 |
| 2025/01/28 | 4,679 | 4,733 | 4,667 | 4,709 | +33 | +0.7% | 1,875,300 |
| 2025/01/27 | 4,629 | 4,696 | 4,615 | 4,676 | +148 | +3.3% | 2,448,300 |
| 2025/01/24 | 4,506 | 4,573 | 4,491 | 4,528 | +42 | +0.9% | 1,914,600 |
| 2025/01/23 | 4,403 | 4,523 | 4,399 | 4,486 | +65 | +1.5% | 1,803,300 |
| 2025/01/22 | 4,350 | 4,438 | 4,343 | 4,421 | +162 | +3.8% | 1,969,200 |
| 2025/01/21 | 4,256 | 4,276 | 4,239 | 4,259 | +33 | +0.8% | 621,100 |
| 2025/01/20 | 4,251 | 4,275 | 4,226 | 4,226 | -14 | -0.3% | 574,000 |
1～
50
件表示中 / 3671件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 392,500円 | +1.7% | -2.9% | 4.08% | 25.75倍 | 1.35倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 140,400円 | +18.5% | -96.0% | 5.27% | 179.54倍 | 1.64倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 225,000円 | +5.7% | +3.9% | 2.55% | 11.20倍 | 1.48倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 212,900円 | -3.5% | -11.3% | 2.82% | 19.55倍 | 1.31倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 154,100円 | -3.5% | -50.2% | 5.19% | 12.48倍 | 0.92倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
